The mysterious illness continues to baffle doctors, leaving affected families in search of answers and a growing concern in the community.
The U.S. saw a proper drop in deaths as COVID-19's impact that still seem less, but other causes like unintentional injuries and chronic diseases remain significant...
US FDA Approves Novartis’ Fabhalta for IgA Nephropathy, Showing 44% Reduction in Urine Protein Levels.
Further doses of the weight- loss medicine Wegovy are now available in the U.S., but force challenges and high demand persist.
COVID-19 cases are rising again due to the new Omicron variant KP3.1.1, with increased indoor gatherings and the ongoing need for masking and vaccinations.
A study shows a link between ADHD and narcissistic traits which is specially tied to hyperactivity and impulsivity which offers new insights for managing ADHD.
New study concluded that consistent healthy blood vessels is important for preventing cognitive decline and neurodegenerative disorders like Alzheimer’s disease and many more.
The study implicates that diabetes drugs like Ozempic could slow Alzheimer’s decline, but further research with larger trials is needed.
The FDA's approval of the Shield blood test gives a new screening option for the colon cancer, but it still needs to follow-up colonoscopies to confirm...
Long Covid remains controversial, highlighting the need for rigorous scientific evidence and caution against exploitation and misinformation.